EMR
February 7, 2024 - AI Summary
Overvalued by 70.4% based on the discounted cash flow analysis.
Market cap | $62.39 Billion |
---|---|
Enterprise Value | $71.18 Billion |
Dividend Yield | $2.0733 (1.9%) |
Earnings per Share | $19.21 |
Beta | 0.88 |
Outstanding Shares | 570,800,000 |
Avg 30 Day Volume | 1,942,065 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 5.66 |
---|---|
PEG | -6.03 |
Price to Sales | 4.06 |
Price to Book Ratio | 3.05 |
Enterprise Value to Revenue | 4.47 |
Enterprise Value to EBIT | 28.47 |
Enterprise Value to Net Income | 6 |
Total Debt to Enterprise | 0.15 |
Debt to Equity | 0.53 |
No data
No data